Antipsychotic Agents: Clinical Trials

2 trials for Antipsychotic Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Antipsychotic Agents: new trials by email Literature Review of Antipsychotic Agents trials Research Report on Antipsychotic Agents

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
LY03010 156 mg treatment group, deltoid, LY03010 156 mg treatment group, gluteal, LY03010 351 mg treatment group, deltoid - Schizophrenia, Psychotic Disorders
Phase 1CompletedLuye Pharma Group Ltd.892021-09-082024-03-19
Relative Bioavailability of LY03010 Compared to Listed Drug
LY03010; paliperidone palmitate, INVEGA SUSTENNA - Schizophrenia, Psychotic Disorders
Phase 1CompletedLuye Pharma Group Ltd.2812021-01-132023-04-25

Narrower conditions

Mental Disorders (2)  ·  Mood Disorders (2)  ·  Psychotic Disorders (2)  ·  Schizophrenia (2)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)

Broader conditions

Schizophrenia Spectrum and Other Psychotic Disorders (1)

Interventions

Paliperidone Palmitate (2)

Sponsors

Luye Pharma Group Ltd. (2)

Countries

United States (2)

Top investigators

Rui Li, MD (2)

Results publications

PMID 42752599